Over the last 180 days, Sagimet Biosciences Inc. insiders sold a net $4.5M of stock across 23 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 18 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | — | $2.0M | — |
| OPERATING INCOME | $-56.9M | $-54.5M | $-30.7M | $-31.1M |
| NET INCOME | $-51.0M | $-45.6M | $-27.9M | $-30.5M |
| EPS (DILUTED) | -1.58 | -1.45 | -2.66 | -165.20 |
| OPERATING CASH FLOW | $-45.6M | $-42.4M | $-23.8M | $-24.5M |
| CASH | $35.0M | $75.8M | $75.1M | $158.0K |
No password to create and no card required. We store your email address and nothing else.